ORS 441.052: Provision of opioid reversal medication upon discharge or release from hospital.

(1) Upon the discharge or release of a patient, a hospital licensed under this chapter shall provide to the patient at least two doses of an opioid overdose reversal medication and the necessary medical supplies to administer the medication if: (a) The hospital actively treated the patient for the patient’s opioid use disorder; and (b) The patient is discharged or released to an unlicensed private residence or other unlicensed setting. (2)(a) Except as provided in paragraph (b) of this subsection, a person who is acting in good faith, if the act does not constitute wanton misconduct, is immune from civil liability for any act or omission of an act committed during the course of providing to a patient opioid overdose reversal medications, and the necessary medical supplies to administer the medications, under subsection (1) of this section. (b) This subsection does not apply to a person involved in the manufacture or sale of opioid overdose reversal medication. (3) The requirements of subsection (1) of this section do not apply if a patient leaves the hospital against medical advice. [2023 c.297 §2] Sec. 7. The Oregon Health Authority shall facilitate access to opioid overdose reversal medications and the necessary medical supplies to administer the medications for hospitals licensed under ORS chapter 441, long term care facilities as defined in ORS 442.015, facilities as defined in section 4 of this 2023 Act [430.263] and facilities as defined in section 6 of this 2023 Act [443.454] for the purposes of carrying out sections 2 [441.052], 3 [441.698], 4 and 6 of this 2023 Act. [2023 c.297 §7]